Management of Acute Ischemic Stroke

Abstract

Acute ischemic stroke (AIS) is a time-sensitive neurological emergency and it remains to be the most common type of stroke. Rapid neuroimaging is the cornerstone for initiating time-sensitive interventions in the treatment of AIS. Revascularization therapies that were once considered irreversible, including intravenous thrombolysis (IVT) and endovascular treatment (EVT), administered in a timely fashion have revolutionized the treatment of AIS. The indications for these therapies have expanded over the past few years and a lot of advancements are happening every year. IVT is offered to all eligible patients presenting within 3 hours of symptom onset and up to 4.5 hours with additional criteria. EVT with stent retrievers or aspiration devices, once limited to the first 6 hours of stroke onset, is now being offered up to 24 hours with advanced image-guided patient selection, which includes a computed tomography or magnetic resonance perfusion imaging. A protocol-based approach to the management of stroke, beginning from prehospital care reduces the time delay in the initiation of treatment. Providing access to these therapies by creating systems of care, hospital stroke team, and “stroke codes” improves the outcome of patients with AIS.

Keywords

stroke - acute ischemic stroke - intravenous thrombolysis - telestroke - CT perfusion

• References

• 1 The top 10 causes of death: factsheet, World Health Organization. 2017 Available at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death Accessed May 2019
• 2 Feigin VL, Nguyen G, Cercy K. et al; GBD 2016 Lifetime Risk of Stroke Collaborators. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N Engl J Med 2018; 379 (25) 2429-2437
• 3 World Stroke Organization Global Stroke Fact Sheet. Available at http://www.world-stroke.org Accessed May 2019
• 4 Global Burden of Disease Stroke Statistics Worldwide for the year 2016. Available at: http://ghdx.healthdata.org/gbd-results-tool Accessed May 2019
• 5 Benjamin EJ, Blaha MJ, Chiuve SE. et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2017 update a report from the American Heart Association. Circulation 2017; 135 (10) e146-e603
• 6 Saver JL. Time is brain--quantified. Stroke 2006; 37 (01) 263-266
• 7 Berglund A, Svensson L, Wahlgren N. et al. HASTA Collaborators. Face Arm Speech Time Test use in the prehospital setting, better in the ambulance than in the emergency medical communication center. Cerebrovasc Dis 2014; 37: 212-216
• 8 De Luca A, Giorgi Rossi P, Villa GF. et al. Stroke Group Italian Society PreHospital EMERGENCY SERVICES. The use of Cincinnati PrehospitalStroke Scale during telephone dispatch interview increases the accuracy in identifying stroke and transient ischemic attack symptoms. BMC Health Serv Res 2013; 13: 513
• 9 Katz BS, McMullan JT, Sucharew H, Adeoye O, Broderick JP. Design and validation of a prehospital scale to predict stroke severity: Cincinnati Prehospital Stroke Severity Scale. Stroke 2015; 46 (06) 1508-1512
• 10 Ali Reza Noorian MD, Nerses Sanossian MD, Kristina Shkirkova BS. et al. Los Angeles motor scales to identify large vessel occlusion prehospital validation and comparison with other screens. Stroke AHA 2018; 49: 565-572
• 11 Jauch EC, Saver JL, Adams Jr HP. et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44 (03) 870-947
• 12 Higashida R, Alberts MJ, Alexander DN. et al; American Heart Association Advocacy Coordinating Committee. Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke 2013; 44 (10) 2961-2984
• 13 Summers D, Leonard A, Wentworth D. et al; American Heart Association Council on Cardiovascular Nursing and the Stroke Council. Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: a scientific statement from the American Heart Association. Stroke 2009; 40 (08) 2911-2944
• 14 Roffe C, Nevatte T, Sim J. et al; Stroke Oxygen Study Investigators and the Stroke OxygenStudy Collaborative Group. Effect of routine low-dose oxygen supplementation on death and disability in adults with acute stroke: the Stroke Oxygen Study Randomized Clinical Trial. JAMA 2017; 318 (12) 1125-1135
• 15 Perini F, De Boni A, Marcon M, Bolgan I, Pellizzari M, Dionisio LD. Systolic blood pressure contributes to intracerebral haemorrhage after thrombolysis for ischemic stroke. J Neurol Sci 2010; 297 (01) (02) 52-54
• 16 Wohlfahrt P, Krajcoviechova A, Jozifova M. et al. Low blood pressure during the acute period of ischemic stroke is associated with decreased survival. J Hypertens 2015; 33 (02) 339-345
• 17 Lin CB, Peterson ED, Smith EE. et al. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovasc Qual Outcomes 2012; 5 (04) 514-522
• 18 Lyden P, Raman R, Liu L, Emr M, Warren M, Marler J. National Institutes of Health Stroke Scale certification is reliable across multiple venues. Stroke 2009; 40 (07) 2507-2511
• 19 Wardlaw JM, Seymour J, Cairns J, Keir S, Lewis S, Sandercock P. Immediate computed tomography scanning of acute stroke is cost-effective and improves quality of life. Stroke 2004; 35 (11) 2477-2483
• 20 Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000; 3559216: 1670-1674
• 21 Gupta AC, Schaefer PW, Chaudhry ZA. et al. Interobserver reliability of baseline noncontrast CT Alberta Stroke Program Early CT Score for intra-arterial stroke treatment selection. Am J Neuroradiol 2012; 33 (06) 1046-1049
• 22 Dzialowski I, Hill MD, Coutts SB. et al. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke 2006; 37 (04) 973-978
• 23 Hill MD, Demchuk AM, Goyal M. et al; IMS3 Investigators. Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke 2014; 45 (02) 444-449
• 24 Aulicky P, Mikulík R, Goldemund D, Reif M, Dufek M, Kubelka T. Safety of performing CT angiography in stroke patients treated with intravenous thrombolysis. J Neurol Neurosurg Psychiatry 2010; 81 (07) 783-787
• 25 Chalela JA, Kidwell CS, Nentwich LM. et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 2007; 369 (9558) 293-298
• 26 Yu AY, Zerna C, Assis Z. et al. Multiphase CT angiography increases detection of anterior circulation intracranial occlusion. Neurology 2016; 87 (06) 609-616
• 27 Barber PA, Hill MD, Eliasziw M. et al; ASPECTS Study Group. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry 2005; 76 (11) 1528-1533
• 28 Greenberg SM, Vernooij MW, Cordonnier C. et al; Microbleed Study Group. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009; 8 (02) 165-174
• 29 d'Esterre CD, Boesen ME, Ahn SH. et al. Time dependent computed tomographic perfusion thresholds for patients with acute ischemic stroke. Stroke 2015; 46 (12) 3390-3397
• 30 Bivard A, Kleinig T, Miteff F. et al. Ischemic core thresholds change with time to reperfusion: a case control study. Ann Neurol 2017; 82 (06) 995-1003
• 31 Campbell BC, Christensen S, Levi CR. et al. Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke 2011; 42 (12) 3435-3440
• 32 Campbell BC, Yassi N, Ma H. et al. Imaging selection in ischemic stroke: feasibility of automated CT-perfusion analysis. Int J Stroke 2015; 10 (01) 51-54
• 33 Nogueira RG, Jadhav AP, Haussen DC. et al; DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018; 378 (01) 11-21
• 34 Berkhemer OA, Fransen PS, Beumer D. et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372 (01) 11-20
• 35 Demaerschalk BM, Kleindorfer DO, Adeoye OM. et al; American Heart Association Stroke Council and Council on Epidemiology and Prevention. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke. Stroke 2016; 47 (02) 581-641
• 36 Hacke W, Kaste M, Bluhmki E. et al. Thrombolysis with alteplase 3–4.5 h after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329
• 37 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333 (24) 1581-1587
• 38 Hacke W, Kaste M, Fieschi C. et al; The European Cooperative Acute Stroke Study (ECASS). Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 1995; 274 (13) 1017-1025
• 39 Robinson TG, Wang X, Arima H. et al; ENCHANTED Investigators. Low-versus standard-dose alteplase in patients on prior antiplatelet therapy: the enchanted trial (enhanced control of hypertension and thrombolysis stroke study). Stroke 2017; 48 (07) 1877-1883
• 40 Logallo N, Novotny V, Assmus J. et al. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial. Lancet Neurol 2017; 16 (10) 781-788
• 41 Campbell BCV, Mitchell PJ, Churilov L. et al; EXTEND-IA TNK Investigators. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med 2018; 378 (17) 1573-1582
• 42 Thomalla G, Simonsen CZ, Boutitie F. et al; WAKE-UP Investigators. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med 2018; 379 (07) 611-622
• 43 Berkhemer OA, Fransen PS, Beumer D. et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372 (01) 11-20
• 44 Campbell BC, Mitchell PJ, Yan B. et al; EXTEND-IA investigators. A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA). Int J Stroke 2014; 9 (01) 126-132
• 45 Demchuk AM, Goyal M, Menon BK. et al; ESCAPE Trial Investigators. Endovascular treatment for small core and anterior circulation proximal occlusion with emphasis on minimizing CT to recanalization times (ESCAPE) trial: methodology. Int J Stroke 2015; 10 (03) 429-438
• 46 Jovin TG, Chamorro A, Cobo E. et al; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. [REVASCAT] N Engl J Med 2015; 372 (24) 2296-2306
• 47 Saver JL, Jahan R, Levy EI. et al; SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 3809849: 1241-1249
• 48 Bracard S, Ducrocq X, Mas JL. et al; THRACE investigators. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol 2016; 15 (11) 1138-1147
• 49 Mocco J, Zaidat OO, von Kummer R. et al; THERAPY Trial Investigators*. Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke 2016; 47 (09) 2331-2338
• 50 Muir KW, Ford GA, Messow CM. et al; PISTE Investigators. Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised, controlled trial. J Neurol Neurosurg Psychiatry 2017; 88 (01) 38-44
• 51 Khoury NN, Darsaut TE, Ghostine J. et al; EASI trial collaborators. Endovascular thrombectomy and medical therapy versus medical therapy alone in acute stroke: a randomized care trial. J Neuroradiol 2017; 44 (03) 198-202
• 52 Albers GW, Lansberg MG, Kemp S. et al; A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3). Int J Stroke 2017; 12 (08) 896-905
• 53 Goyal M, Jadhav AP, Bonafe A. et al; SWIFT PRIME investigators. Analysis of workflow and time to treatment and the effects on outcome in endovascular treatment of acute ischemic stroke: results from the swift prime randomized controlled trial. Radiology 2016; 279 (03) 888-897
• 54 Yoo AJ, Simonsen CZ, Prabhakaran S. et al; Cerebral Angiographic Revascularization Grading Collaborators. Refining angiographic biomarkers of revascularization: improving outcome prediction after intra-arterial therapy. Stroke 2013; 44 (09) 2509-2512
• 55 Ebinger M, Winter B, Wendt M. et al; STEMO Consortium. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA 2014; 311 (16) 1622-1631
• 56 Walter S, Kostopoulos P, Haass A. et al; Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial. Lancet Neurol 2012; 11 (05) 397-404
• 57 Hastrup S, Damgaard D, Johnsen SP, Andersen G. Prehospital acute stroke severity scale to predict large artery occlusion: design and comparison with other scales. Stroke 2016; 47 (07) 1772-1776
• 58 Kamal N, Holodinsky JK, Stephenson C. et al; Improving door-to-needle times for acute ischemic stroke: effect of rapid patient registration, moving directly to computed tomography, and giving alteplase at the computed tomography scanner. Circ Cardiovasc Qual Outcomes. 2017 10. (1)
• 59 Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007; 17 (04) CD000197
• 60 Wareham J, Flood R, Phan K. et al. A systematic review and meta-analysis of observational evidence for the use of bailout self-expandable stents following failed anterior circulation stroke thrombectomy. J NeuroInterv Surg. 2018 doi: 10.1136/neurintsurg-2018-014459.
• 61 Brinjikji W, Murad MH, Rabinstein AA, Cloft HJ, Lanzino G, Kallmes DF. Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: a systematic review and meta-analysis. AJNR Am J Neuroradiol 2015; 36 (03) 525-529
• 62 Simonsen CZ, Yoo AJ, Sørensen LH. et al; Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke: a randomized clinical trial. JAMA Neurol 2018; 75 (04) 470-477
• 63 Löwhagen Hendén P, Rentzos A, Karlsson JE. et al; General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke (The AnStroke Trial). Stroke 2017; 48 (06) 1601-1607
• 64 Schönenberger S, Uhlmann L, Hacke W. et al. Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: a randomized controlled trial. JAMA 2016; 316 (19) 1986-1996
• 65 Peng Y, Wu Y, Huo X. et al; Endovascular Therapy for Acute Ischemic Stroke Trial (EAST) group. Outcomes of anesthesia selection in endovascular treatment of acute ischemic stroke. J Neurosurg Anesthesiol 2019; 31 (01) 43-49
• 66 Talke PO, Sharma D, Heyer EJ, Bergese SD, Blackham KA, Stevens RD. Society for Neuroscience in Anesthesiology and Critical Care Expert consensus statement: anesthetic management of endovascular treatment for acute ischemic stroke*: endorsed by the Society of NeuroInterventional Surgery and the Neurocritical Care Society. J Neurosurg Anesthesiol 2014; 26 (02) 95-108
• 67 Fischer U, Baumgartner A, Arnold M. et al. What is a minor stroke?. Stroke 2010; 41 (04) 661-666
• 68 Ahmed N, Wahlgren N, Grond M. et al; SITS investigators. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol 2010; 9 (09) 866-874
• 69 Powers WJ, Rabinstein AA, Ackerson T. et al; American Heart Association Stroke Council. Guidelines for the Early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018; 49 (03) e46-e110
• 70 Coutts SB, Modi J, Patel SK. et al; What causes disability after transient ischemic attack and minor stroke?: results from the CT and MRI in the triage of TIA and minor Cerebrovascular Events to Identify High Risk Patients (CATCH) Study. Stroke 2012; 43 (11) 3018-3022
• 71 Bivard A, Huang X, Levi CR. et al. Tenecteplase in ischemic stroke offers improved recanalization: analysis of 2 trials. Neurology 2017; 89 (01) 62-67
• 72 Raco A, Caroli E, Isidori A, Salvati M. Management of acute cerebellar infarction: one institution's experience. Neurosurgery 2003; 53 (05) 1061-1065 discussion 1065–1066
• 73 Agarwalla PK, Stapleton CJ, Ogilvy CS. Craniectomy in acute ischemic stroke. Neurosurgery 2014; 74 (Suppl. 01) S151-S162
• 74 Dittrich R, Kloska SP, Fischer T. et al. Accuracy of perfusion-CT in predicting malignant middle cerebral artery brain infarction. J Neurol 2008; 255 (06) 896-902
• 75 Oppenheim C, Samson Y, Manaï R. et al. Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke 2000; 31 (09) 2175-2181
• 76 Kasner SE, Demchuk AM, Berrouschot J. et al. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke 2001; 32 (09) 2117-2123
• 77 Vahedi K, Vicaut E, Mateo J. et al; DECIMAL Investigators. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke 2007; 38 (09) 2506-2517
• 78 Jüttler E, Schwab S, Schmiedek P. et al; DESTINY Study Group. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke 2007; 38 (09) 2518-2525
• 79 Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB. HAMLET investigators. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 2009; 8 (04) 326-333
• 80 Vahedi K, Hofmeijer J, Juettler E. et al; DECIMAL, DESTINY, and HAMLET investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6 (03) 215-222
• 81 Jüttler E, Unterberg A, Woitzik J. et al; DESTINY II Investigators. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med 2014; 370 (12) 1091-1100
• 82 CAST. Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke: CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997; 349: 1641-1649
• 83 Wang Y, Wang Y, Zhao X. et al; CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013; 369 (01) 11-19
• 84 Johnston SC, Easton JD, Farrant M. et al; Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med 2018; 379 (03) 215-225
• 85 Tillman H, Johnston SC, Farrant M. et al. Risk for major hemorrhages in patients receiving clopidogrel and aspirin compared with aspirin alone after transient ischemic attack or minor ischemic stroke: a secondary analysis of the POINT randomized clinical trial. JAMA Neurol. 2019 Epubaheadof print 29 April 2019 DOI 10.1001/jamaneurol.2019.0932
• 86 Gubitz G, Sandercock P, Counsell C. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 2004; (03) CD000024
• 87 Lyden P, Hemmen T, Grotta J. et al; Collaborators. Results of the ICTuS 2 trial (Intravascular Cooling in the Treatment of Stroke 2). Stroke 2016; 47 (12) 2888-2895
• 88 Geurts M, Petersson J, Brizzi M. et al. COOLIST (Cooling for Ischemic Stroke Trial): a multicenter, open, randomized, phase ii, clinical trial. Stroke 2017; 48 (01) 219-221
• 89 Green AR. Why do neuroprotective drugs that are so promising in animals fail in the clinic?. An industry perspective. Clin Exp Pharmacol Physiol 2002; 29 (11) 1030-1034
• 90 Saver JL, Starkman S, Eckstein M. et al; FAST-MAG Investigators and Coordinators. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med 2015; 372 (06) 528-536
• 91 Nacu A, Kvistad CE, Naess H. et al. NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study): randomized controlled contrast-enhanced sonothrombolysis in an unselected acute ischemic stroke population. Stroke 2017; 48 (02) 335-341
• 92 Joundi RA, Martino R, Saposnik G, Giannakeas V, Fang J, Kapral MK. Predictors and outcomes of dysphagia screening after acute ischemic stroke. Stroke 2017; 48 (04) 900-906
• 93 Fonarow GC, Zhao X, Smith EE. et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA 2014; 311 (16) 1632-1640
• 94 Heffner DL, Thirumala PD, Pokharna P, Chang YF, Wechsler L. Outcomes of spoke-retained telestroke patients versus hub-treated patients after intravenous thrombolysis: telestroke patient outcomes after thrombolysis. Stroke 2015; 46 (11) 3161-3167
• 95 Sanders KA, Patel R, Kiely JM, Gwynn MW, Johnston LH. Improving telestroke treatment times in an expanding network of hospitals. J Stroke Cerebrovasc Dis 2016; 25 (02) 288-291
• 96 Fassbender K, Walter S, Liu Y. et al. “Mobile stroke unit” for hyperacute stroke treatment. Stroke 2003; 34 (06) e44
• 97 Walter S, Kostpopoulos P, Haass A. et al. Bringing the hospital to the patient: first treatment of stroke patients at the emergency site. PLoS One 2010; 5 (10) e13758
• 98 Ebinger M, Kunz A, Wendt M. et al. Effects of golden hour thrombolysis: a Prehospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) sub-study. JAMA Neurol 2015; 72 (01) 25-30